Search research articles
Contact Us
Filters
Showing results (61-70 of 71) with videos related to
Page
of 8
Sort By:
European Journal of Medicinal Chemistry
|
January 10, 2025
Repurposing FDA-approved drugs to target G-quadruplexes in breast cancer
Federica Moraca, Valentina Arciuolo, Simona Marzano, et al.
Biochimie
|
May 9, 2017
Characterization of linear mimetic peptides of Interleukin-22 from dissection of protein interfaces
Sara La Manna, Pasqualina Liana Scognamiglio, Concetta Di Natale, et al.
Oncotarget
|
May 27, 2015
Cannabinoid receptor CB1 regulates STAT3 activity and its expression dictates the responsiveness to SR141716 treatment in human glioma patients' cells
Elena Ciaglia, Giovanni Torelli, Simona Pisanti, et al.
Frontiers in Oncology
|
July 30, 2019
The Oncolytic Virus <i>dl</i>922-947 Triggers Immunogenic Cell Death in Mesothelioma and Reduces Xenograft Growth
Sarah Di Somma, Carmelina Antonella Iannuzzi, Carmela Passaro, et al.
Viruses
|
December 28, 2021
The Oncolytic Caprine Herpesvirus 1 (CpHV-1) Induces Apoptosis and Synergizes with Cisplatin in Mesothelioma Cell Lines: A New Potential Virotherapy Approach
Iris Maria Forte, Paola Indovina, Serena Montagnaro, et al.
European Journal of Medicinal Chemistry
|
April 10, 2012
Rational design, synthesis and anti-proliferative properties of new CB2 selective cannabinoid receptor ligands: an investigation of the 1,8-naphthyridin-2(1H)-one scaffold
Clementina Manera, Giuseppe Saccomanni, Anna Maria Malfitano, et al.
Molecules (Basel, Switzerland)
|
May 14, 2022
Synthesis and In Vitro Characterization of Selective Cannabinoid CB2 Receptor Agonists: Biological Evaluation against Neuroblastoma Cancer Cells
Francesca Gado, Rebecca Ferrisi, Sarah Di Somma, et al.
Frontiers in Immunology
|
September 5, 2022
Immunological signature of patients with thymic epithelial tumors and Good syndrome
Anna Maria Malfitano, Vittoria D'Esposito, Pietro De Placido, et al.
European Journal of Medicinal Chemistry
|
February 13, 2014
1,2-Dihydro-2-oxopyridine-3-carboxamides: the C-5 substituent is responsible for functionality switch at CB2 cannabinoid receptor
Valentina Lucchesi, Teija Parkkari, Juha R Savinainen, et al.
European Journal of Medicinal Chemistry
|
May 4, 2015
New quinolone- and 1,8-naphthyridine-3-carboxamides as selective CB2 receptor agonists with anticancer and immuno-modulatory activity
Clementina Manera, Anna Maria Malfitano, Teija Parkkari, et al.
Page
of 8
Search research articles
Search
Showing results (61-70 of 71) with videos related to
Sort By:
Page
of 8
European Journal of Medicinal Chemistry
|
January 10, 2025
Repurposing FDA-approved drugs to target G-quadruplexes in breast cancer
Federica Moraca, Valentina Arciuolo, Simona Marzano, et al.
Biochimie
|
May 9, 2017
Characterization of linear mimetic peptides of Interleukin-22 from dissection of protein interfaces
Sara La Manna, Pasqualina Liana Scognamiglio, Concetta Di Natale, et al.
Oncotarget
|
May 27, 2015
Cannabinoid receptor CB1 regulates STAT3 activity and its expression dictates the responsiveness to SR141716 treatment in human glioma patients' cells
Elena Ciaglia, Giovanni Torelli, Simona Pisanti, et al.
Frontiers in Oncology
|
July 30, 2019
The Oncolytic Virus <i>dl</i>922-947 Triggers Immunogenic Cell Death in Mesothelioma and Reduces Xenograft Growth
Sarah Di Somma, Carmelina Antonella Iannuzzi, Carmela Passaro, et al.
Viruses
|
December 28, 2021
The Oncolytic Caprine Herpesvirus 1 (CpHV-1) Induces Apoptosis and Synergizes with Cisplatin in Mesothelioma Cell Lines: A New Potential Virotherapy Approach
Iris Maria Forte, Paola Indovina, Serena Montagnaro, et al.
European Journal of Medicinal Chemistry
|
April 10, 2012
Rational design, synthesis and anti-proliferative properties of new CB2 selective cannabinoid receptor ligands: an investigation of the 1,8-naphthyridin-2(1H)-one scaffold
Clementina Manera, Giuseppe Saccomanni, Anna Maria Malfitano, et al.
Molecules (Basel, Switzerland)
|
May 14, 2022
Synthesis and In Vitro Characterization of Selective Cannabinoid CB2 Receptor Agonists: Biological Evaluation against Neuroblastoma Cancer Cells
Francesca Gado, Rebecca Ferrisi, Sarah Di Somma, et al.
Frontiers in Immunology
|
September 5, 2022
Immunological signature of patients with thymic epithelial tumors and Good syndrome
Anna Maria Malfitano, Vittoria D'Esposito, Pietro De Placido, et al.
European Journal of Medicinal Chemistry
|
February 13, 2014
1,2-Dihydro-2-oxopyridine-3-carboxamides: the C-5 substituent is responsible for functionality switch at CB2 cannabinoid receptor
Valentina Lucchesi, Teija Parkkari, Juha R Savinainen, et al.
European Journal of Medicinal Chemistry
|
May 4, 2015
New quinolone- and 1,8-naphthyridine-3-carboxamides as selective CB2 receptor agonists with anticancer and immuno-modulatory activity
Clementina Manera, Anna Maria Malfitano, Teija Parkkari, et al.
Page
of 8